MENU
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cartesian Therapeutics (RNAC) Ownership - Who owns Cartesian Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
483.14M
P/E Ratio
N/A
Total Cash
219.2M
Projected Growth
N/A
Total Debt
14.65M
Revenue
47.94M
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash/Share
8.62
Total Debt/Equity
N/A
Revenue/Share
9.66 USD as % of share price
Fundamentals
RNAC
Capitalization
483M
P/E Ratio
N/A
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash
219M
Total Cash/Share
8.62
Total Debt
14.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.66%
Revenue
47.9M
ROE
N/A
Book Value
752K
P/B Ratio
625.00
Cash Flow
N/A
Earnings
-55.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
10.70
Current Revenue Per Employee
10184.21
Dividends Per Share - Security
N/A
EBITDA
-262.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-87.23
Shares Held By Institutions
183M
Shares Outstanding - Current
25.4M
Total Liabilities
455M
Total Volume MTD
N/A
Value
-1
Gain YTD
-8.036
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of targeted immunotherapies and vaccines to treat and prevent diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com